Neogen Chemicals Falls to 52-Week Low of Rs.1112.55 Amidst Prolonged Underperformance

Stock Price Movement and Market Context

On 2 December 2025, Neogen Chemicals’ stock price touched Rs.1112.55, marking its lowest level in the past 52 weeks. This price point represents a decline of nearly 53.9% from its 52-week high of Rs.2414.90. The stock’s performance today showed a marginal fall of 0.80%, underperforming the specialty chemicals sector by 0.92%. Furthermore, the share price is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating sustained downward momentum.

In comparison, the Sensex opened lower by 316.39 points and was trading at 85,308.86, down 0.39% on the day. Despite this, the Sensex remains close to its 52-week high of 86,159.02 and is positioned above its 50-day and 200-day moving averages, signalling a generally bullish trend in the broader market. This contrast highlights the relative weakness in Neogen Chemicals’ stock performance over the same period.

Financial Performance and Profitability Metrics

Neogen Chemicals’ financial indicators over recent quarters have shown subdued results. The company reported a net profit after tax (PAT) of Rs.3.37 crore in the latest quarter, which is 68.5% lower compared to the average of the previous four quarters. This decline in profitability has contributed to the stock’s downward trajectory.

The company’s return on capital employed (ROCE) for the half-year period stands at 5.72%, reflecting limited efficiency in generating returns from its capital base. This figure is relatively low, especially when considering the company’s enterprise value to capital employed ratio of 2.2, which suggests a valuation that may be considered expensive relative to the returns generated.

Operating profit growth over the last five years has averaged 14.16% annually, indicating modest expansion in core earnings. However, recent quarters have seen negative results declared consecutively, signalling challenges in sustaining growth momentum.

Debt Levels and Interest Burden

One of the notable concerns for Neogen Chemicals is its elevated debt servicing burden. The company’s debt to EBITDA ratio stands at 4.01 times, indicating a relatively high level of debt compared to earnings before interest, taxes, depreciation, and amortisation. This ratio suggests that the company may face challenges in comfortably meeting its debt obligations from operational earnings.

Interest expenses have also shown a marked increase, with quarterly interest costs rising by 53.75% to Rs.19.48 crore. This escalation in interest payments adds pressure on the company’s profitability and cash flow, further complicating its financial position.

Shareholder Returns and Market Capitalisation

Neogen Chemicals has generated a return on equity (ROE) averaging 9.65%, which points to relatively low profitability per unit of shareholders’ funds. Over the past year, the stock has delivered a total return of -47.75%, significantly lagging behind the Sensex’s 6.30% return during the same period. This underperformance extends to longer time frames as well, with the stock trailing the BSE500 index over one year, three years, and the most recent three months.

The company’s market capitalisation is graded at a modest level, reflecting its size within the specialty chemicals sector. Despite the subdued stock price, institutional investors hold a substantial stake of 30.38%, indicating a significant presence of resourceful shareholders with the capability to analyse company fundamentals.

Valuation and Peer Comparison

Neogen Chemicals’ valuation metrics suggest that the stock is trading at a discount relative to its peers’ average historical valuations. However, this discount accompanies a combination of low returns on capital and elevated debt levels, which may be factors influencing the market’s assessment of the company’s prospects.

Summary of Recent Trends

Neogen Chemicals’ stock has experienced a sustained decline over the past year, with a near halving of its share price from the 52-week high. The company’s financial results have reflected subdued profitability, rising interest expenses, and a relatively high debt burden. These factors have contributed to the stock trading below all major moving averages and underperforming both its sector and the broader market indices.

While the stock is currently valued at a discount compared to peers, the combination of low returns on equity and capital employed, alongside recent negative quarterly results, has influenced the market’s cautious stance. Institutional investors maintain a significant holding, which may reflect a longer-term perspective on the company’s fundamentals.

Overall, Neogen Chemicals’ current stock price at Rs.1112.55 marks a notable low point in its recent trading history, underscoring the challenges faced by the company within the specialty chemicals sector.

Get 1 year of Weekly Picks FREE when you subscribe to MojoOne. Offer ends soon. Start Saving Now →